Accelerating BioVenture Innovation

Accelerating BioVenture Innovation

ABI is our 12-week course and training program in biomedical entrepreneurship. ABI  builds teams around patented technologies originating from Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and Rockefeller University

For further information, contact:

Connor Dowling
Associate, BioVenture eLab
BioPharma Alliances and Research Collaborations
Weill Cornell Medicine
T 646-962-6186
@CDNYCY4 (Twitter)

Need more info?
Ask a question
Follow us on

Weill Cornell Medicine Graduate School of Medical Sciences 1300 York Ave. Box 65 New York, NY 10065 Phone: (212) 746-6565 Fax: (212) 746-5981